KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Total Non-Current Liabilities: 2017-2025

Historic Total Non-Current Liabilities for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $2.5 billion.

  • Moderna's Total Non-Current Liabilities fell 29.89% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 29.89%. This contributed to the annual value of $3.0 billion for FY2024, which is 31.09% down from last year.
  • Moderna's Total Non-Current Liabilities amounted to $2.5 billion in Q3 2025, which was up 8.09% from $2.3 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Total Non-Current Liabilities registered a high of $10.8 billion during Q3 2021, and its lowest value of $2.3 billion during Q2 2025.
  • In the last 3 years, Moderna's Total Non-Current Liabilities had a median value of $3.6 billion in 2024 and averaged $3.7 billion.
  • In the last 5 years, Moderna's Total Non-Current Liabilities surged by 1,981.24% in 2021 and then tumbled by 51.17% in 2023.
  • Over the past 5 years, Moderna's Total Non-Current Liabilities (Quarterly) stood at $10.4 billion in 2021, then crashed by 36.83% to $6.6 billion in 2022, then tumbled by 34.61% to $4.3 billion in 2023, then tumbled by 31.09% to $3.0 billion in 2024, then decreased by 29.89% to $2.5 billion in 2025.
  • Its Total Non-Current Liabilities stands at $2.5 billion for Q3 2025, versus $2.3 billion for Q2 2025 and $2.4 billion for Q1 2025.